- Home
- CHPT vs NPCE Comparison
CHPT vs NPCE Comparison
Compare CHPT & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHPT
- NPCE
- Stock Information
- Founded
- CHPT 2007
- NPCE 1997
- Country
- CHPT United States
- NPCE United States
- Employees
- CHPT N/A
- NPCE N/A
- Industry
- CHPT Industrial Specialties
- NPCE Medical Specialities
- Sector
- CHPT Consumer Discretionary
- NPCE Health Care
- Exchange
- CHPT Nasdaq
- NPCE Nasdaq
- Market Cap
- CHPT 340.1M
- NPCE 292.9M
- IPO Year
- CHPT N/A
- NPCE 2021
- Fundamental
- Price
- CHPT $10.39
- NPCE $9.86
- Analyst Decision
- CHPT Hold
- NPCE Strong Buy
- Analyst Count
- CHPT 10
- NPCE 6
- Target Price
- CHPT $19.11
- NPCE $16.67
- AVG Volume (30 Days)
- CHPT 495.8K
- NPCE 201.4K
- Earning Date
- CHPT 09-03-2025
- NPCE 11-11-2025
- Dividend Yield
- CHPT N/A
- NPCE N/A
- EPS Growth
- CHPT N/A
- NPCE N/A
- EPS
- CHPT N/A
- NPCE N/A
- Revenue
- CHPT $397,731,000.00
- NPCE $88,570,000.00
- Revenue This Year
- CHPT $2.79
- NPCE $22.13
- Revenue Next Year
- CHPT $24.20
- NPCE $6.07
- P/E Ratio
- CHPT N/A
- NPCE N/A
- Revenue Growth
- CHPT N/A
- NPCE 23.32
- 52 Week Low
- CHPT $8.55
- NPCE $5.45
- 52 Week High
- CHPT $31.40
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- CHPT 43.23
- NPCE 59.14
- Support Level
- CHPT $10.01
- NPCE $9.60
- Resistance Level
- CHPT $10.85
- NPCE $10.24
- Average True Range (ATR)
- CHPT 0.57
- NPCE 0.39
- MACD
- CHPT -0.07
- NPCE 0.12
- Stochastic Oscillator
- CHPT 38.81
- NPCE 76.92
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.